New drug combination passes safety test in pancreatic cancer
A new study has shown a novel peptide antagonist, given in combination with a PD-1…
Browsing: PD-1 inhibitor
Study reveals a new approach to enhancing response to immunotherapy in melanoma
US scientists have identified a new way to boost the immune system’s ability to fight…
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma
A new analysis shows that a donor stem cell transplant following treatment with an immune…
A single dose of a PD-1 inhibitor before surgery predicts outcomes in melanoma patients
A single dose of a PD-1 inhibitor before surgery for melanoma can put patients in…
ASCO 2016: PD-1 inhibitor pembrolizumab provides long-term survival benefit
Long-term follow-up from a phase Ib trial (KEYNOTE-001) in newly diagnosed and previously treated patients…